Regis Gabriel Stentz

Title: Innovations of Regis Gabriel Stentz

Introduction

Regis Gabriel Stentz is a notable inventor based in Norwich, GB. He has made significant contributions to the field of biotechnology, particularly in the area of vaccine delivery and therapeutic proteins. With a total of three patents to his name, Stentz's work is at the forefront of innovative medical solutions.

Latest Patents

One of his latest patents is titled "Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract." This invention focuses on the delivery of heterologous peptides or proteins, such as therapeutic peptides, therapeutic proteins, or antigens, to mucosal sites using vesicles derived from the outer membrane of commensal bacteria. It also includes recombinant bacteria capable of producing such vesicles and methods for their production. Another significant patent is "Gut bacteria derived microvesicles for vaccine delivery." This invention relates to a vaccine suitable for immunization against influenza and plague, comprising outer membrane vesicles (OMVs) that include the V and/or F1 antigens.

Career Highlights

Throughout his career, Regis Gabriel Stentz has worked with prominent organizations such as Quadram Institute Bioscience and UEA Enterprises Limited. His work has been instrumental in advancing the understanding and application of gut microbiota in medical science.

Collaborations

Stentz has collaborated with various professionals in his field, including Simon Richard Carding, enhancing the impact of his research and innovations.

Conclusion

Regis Gabriel Stentz is a pioneering inventor whose work in biotechnology is shaping the future of vaccine delivery and therapeutic applications. His patents reflect a commitment to improving health outcomes through innovative solutions.